Guy Bormans Selected Research

Guy Bormans Research Topics

Disease

30	Neoplasms (Cancer) 03/2024 - 03/2006
13	Alzheimer Disease (Alzheimer's Disease) 12/2022 - 03/2009
11	Neuroinflammatory Diseases 01/2020 - 01/2014
11	Necrosis 01/2020 - 08/2005
11	Parkinson Disease (Parkinson's Disease) 10/2019 - 11/2006
7	Schizophrenia (Dementia Praecox) 01/2017 - 01/2013
6	Huntington Disease (Huntington's Disease) 12/2022 - 09/2010
6	Pain (Aches) 01/2018 - 04/2010
5	Inflammation (Inflammations) 10/2019 - 03/2007
4	Central Nervous System Diseases (CNS Diseases) 12/2023 - 07/2011
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2023 - 01/2020
4	Alcoholism (Alcohol Abuse) 01/2022 - 02/2014
4	Cognitive Dysfunction 01/2022 - 08/2007
3	Melanoma (Melanoma, Malignant) 01/2023 - 01/2019
3	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 08/2012
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 09/2019
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 08/2017
3	Primary Progressive Aphasia 01/2020 - 01/2017
3	Rhabdomyosarcoma 01/2020 - 02/2009
3	Tauopathies 01/2020 - 06/2015
3	Anorexia Nervosa 02/2014 - 03/2007
3	Obesity 01/2014 - 01/2008
3	Neurogenic Inflammation 11/2013 - 01/2013
3	Hepatic Infarction 01/2011 - 11/2007
3	Infarction (Infarctions) 01/2008 - 01/2006
3	Myocardial Infarction 01/2008 - 08/2005
2	Leukemia 03/2024 - 01/2020
2	Mental Disorders (Mental Disorder) 01/2022 - 05/2010
2	Neoplasm Metastasis (Metastasis) 04/2021 - 01/2020
2	Atrophy 01/2018 - 01/2017
2	Pulmonary Arterial Hypertension 12/2017 - 02/2014
2	Amyloidosis 11/2016 - 08/2009
2	Anorexia 02/2014 - 10/2011
2	Feeding and Eating Disorders (Eating Disorder) 02/2014 - 10/2011
2	Hypersensitivity (Allergy) 07/2010 - 05/2007
1	Multiple Myeloma 03/2024
1	Glioblastoma (Glioblastoma Multiforme) 01/2023
1	Ischemia 01/2023
1	Neuroblastoma 01/2023
1	Paraganglioma (Paragangliomas) 01/2023

Drug/Important Bio-Agent (IBA)

12	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2022 - 06/2008
10	EndocannabinoidsIBA 12/2023 - 03/2008
6	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2014
6	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2022 - 01/2013
6	Biomarkers (Surrogate Marker)IBA 10/2021 - 08/2009
6	LigandsIBA 09/2020 - 04/2007
6	Ethanol (Ethyl Alcohol)IBA 02/2014 - 07/2007
6	hypericinIBA 12/2012 - 12/2003
5	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 03/2024 - 01/2020
5	Radioisotopes (Radionuclides)IBA 04/2021 - 07/2010
5	Purinergic P2X7 ReceptorsIBA 01/2020 - 01/2016
5	Amyloid (Amyloid Fibrils)IBA 01/2020 - 08/2007
5	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 10/2019 - 10/2015
5	CannabinoidsIBA 01/2019 - 01/2008
5	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 02/2014 - 02/2010
4	Somatostatin Receptors (Somatostatin Receptor)IBA 03/2023 - 01/2018
4	fosbretabulin (combretastatin A4)IBA 01/2020 - 09/2011
4	salicylhydroxamic acid (SHAM)IBA 11/2012 - 05/2007
3	Octreotide (Sandostatin)FDA LinkGeneric 06/2023 - 01/2020
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2023 - 01/2018
3	Amyloid beta-PeptidesIBA 01/2022 - 03/2009
3	EnzymesIBA 01/2022 - 01/2013
3	Metabotropic Glutamate 5 ReceptorIBA 01/2020 - 12/2015
3	Contrast MediaIBA 01/2020 - 08/2005
3	LipopolysaccharidesIBA 12/2018 - 10/2015
3	Guanosine Monophosphate (5' Guanylic Acid)IBA 12/2017 - 01/2014
3	SolutionsIBA 10/2015 - 03/2006
3	Pentetic Acid (DTPA)FDA LinkGeneric 06/2013 - 11/2007
3	Oxidopamine (6 Hydroxydopamine)IBA 02/2010 - 11/2006
2	plerixafor FDA Link 03/2024 - 10/2021
2	68Ga-pentixaforIBA 03/2024 - 10/2021
2	6- amino- 8- ((6- iodo- 1,3- benzodioxol- 5- yl)thio)- N- (1- methylethyl)- 9H-purine-9-propanamineIBA 01/2023 - 01/2019
2	tau Proteins (tau Protein)IBA 01/2023 - 01/2019
2	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2022 - 01/2020
2	Therapeutic UsesIBA 01/2021 - 10/2015
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2021 - 11/2016
2	Gallium-68IBA 01/2020 - 07/2010
2	Levodopa (L Dopa)FDA LinkGeneric 10/2019 - 03/2012
2	Phosphates (Orthophosphate)IBA 07/2018 - 08/2017
2	Dihydrotachysterol (AT 10)IBA 07/2018 - 08/2017
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 12/2017 - 02/2014
2	2- oxo- 7- methoxy- 8- butyloxy- 1,2- dihydroquinoline- 3- carboxylic acid cyclohexylamideIBA 11/2016 - 08/2013
2	CationsIBA 04/2013 - 01/2013
2	IodineIBA 07/2012 - 09/2011
2	pamoic acidIBA 07/2010 - 11/2007
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2007 - 01/2005
1	CXC ChemokinesIBA 03/2024
1	RadiopharmaceuticalsIBA 08/2023
1	(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA 01/2023
1	AntigensIBA 01/2023
1	18F-JK-PSMA-7IBA 01/2023
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2023
1	Muscarinic M4 ReceptorIBA 12/2022
1	Dopamine (Intropin)FDA LinkGeneric 01/2022
1	Apolipoproteins E (ApoE)IBA 01/2022

Therapy/Procedure

14	Therapeutics 08/2023 - 01/2005
5	Drug Therapy (Chemotherapy) 01/2020 - 07/2003
3	Aftercare (After-Treatment) 01/2020 - 03/2007
2	Prostatectomy (Retropubic Prostatectomy) 01/2023 - 08/2012
2	Gastric Balloon 10/2013 - 05/2007